文献速递生殖医学

母体外显子组分析用于诊断卵母细胞成熟缺陷和早期胚胎发育停滞

Maternal exome analysis for the diagnosis of oocyte maturation defects and early embryonic developmental arrest.
PubMed 文献 · Reprod Biomed Online · 2022-05-21

研究开发了一套病例筛选与全外显子组测序(WES)分析方法,用于因复发性卵母细胞成熟缺陷(OOMD)和/或植入前胚胎致死(PREMBL)而不孕的女性。基于11221对夫妇的IVF数据建立统计方法识别内表型,对28例患者行WES,发现7例(25%)携带已知候选基因的纯合错义致病变异,并发现ENSA为新关联基因。

要点

  • 基于大样本IVF数据可统计识别复发性低卵母细胞成熟率、低受精率及植入前发育停滞等内表型。
  • 28例OOMD/PREMBL患者中7例(25%)携带PATL2、NLRP5、TLE6、PADI6、TUBB8或TRIP13的纯合错义致病变异。
  • 一例低卵母细胞成熟率患者为ENSA高影响变异纯合携带者,提示新基因-疾病关联。

核心结论

  • 该分析框架可揭示与孤立性复发性OOMD/PREMBL相关的已知和新基因,为将该策略扩展至更大规模研究提供必要指征。

研究设计与样本

  • 数据收集自2015年至2021年在伊斯坦布尔纪念医院就诊的IVF患者。
  • 利用大型IVF数据集(11221对夫妇)开发统计方法识别不孕内表型(复发性低卵母细胞成熟率、低受精率和植入前发育停滞)。
  • 随后纳入28例OOMD/PREMBL不孕女性,对其基因组DNA行全外显子组测序(WES)。
  • WES和生物信息学分析在Igenomix和意大利国家研究委员会完成。

主要发现

  • 变异优先级分析鉴定出248个基因中的265个独特变异(平均每样本22.4个)。
  • 携带高影响变异的基因中78%由MII卵母细胞和/或窦卵泡颗粒细胞表达,显著高于对照随机样本(比值比=5,Fisher精确检验P=0.0004)。
  • 28例女性中7例(25%)为已知OOMD/PREMBL候选基因(包括PATL2、NLRP5(n=2)、TLE6、PADI6、TUBB8和TRIP13)错义致病变异的纯合携带者。
  • 一例低卵母细胞成熟率女性为ENSA高影响变异的纯合携带者,ENSA是小鼠第一次减数分裂前期转变的必需基因。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Can a methodology be developed for case selection and whole-exome sequencing (WES) analysis of women who are infertile owing to recurrent oocyte maturation defects (OOMD) and/or preimplantation embryo lethality (PREMBL)? DESIGN: Data were collected from IVF patients attending the Istanbul Memorial Hospital (2015-2021). A statistical methodology to identify infertile endophenotypes (recurrent low oocyte maturation rate, low fertilization rate and preimplantation developmental arrest) was developed using a large IVF dataset (11,221 couples). Twenty-eight infertile women with OOMD/PREMBL were subsequently enrolled for WES on their genomic DNA. Pathogenic variants were prioritized using a custom-made bioinformatic pipeline set to minimize false-positive discoveries through resampling in control cohorts (the Human Genome Diversity Project and 1343 whole-exome sequences from oocyte donors). Individual single-cell RNA sequencing data from 18 human metaphase II (MII) oocytes and antral granulosa cells was used for genome-wide validation. WES and bioinformatics were performed at Igenomix and the National Research Council, Italy. RESULTS: Variant prioritization analysis identified 265 unique variants in 248 genes (average 22.4 per sample). Of the genes harbouring high-impact variants 78% were expressed by MII oocytes and/or antral granulosa cells, significantly higher than for random sample of controls (odds ratio = 5, Fisher's exact P = 0.0004). Seven of the 28 women (25%) were homozygous carriers of missense pathogenic variants in known candidate genes for OOMD/PREMBL, including PATL2, NLRP5 (n = 2),TLE6, PADI6, TUBB8 and TRIP13. Furthermore, novel gene-disease associations were identified. In fact, one woman with a low oocyte maturation rate was a homozygous carrier of high-impact variants in ENSA, an essential gene for prophase I meiotic transition in mice. CONCLUSIONS: This analytical framework could reveal known and new genes associated with isolated recurrent OOMD/PREMBL, providing essential indications for scaling this strategy to larger studies.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Capalbo A, Buonaiuto S, Figliuzzi M, et al. Maternal exome analysis for the diagnosis of oocyte maturation defects and early embryonic developmental arrest. Reprod Biomed Online. 2022. PMID: 35798635. doi:10.1016/j.rbmo.2022.05.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。